Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

The firm decreased its portfolio allocation in MRK by 78.58% over the last quarter. Merck Background Information (This description is provided by the company.) For 130 years, Merck, known as MSD ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

The firm decreased its portfolio allocation in MRK by 78.58% over the last quarter. Merck Background Information (This description is provided by the company.) For 130 years, Merck, known as MSD ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best depressed stocks to invest in now. The US stocks ended 2024 with a healthy Q4 ...